NDC11 70594003401
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 70594-0034-01 | 70594-0034 |
| 70594-0034-1 | 70594-0034 |
| 70594-034-01 | 70594-034 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Daptomycin | DAPTOMYCIN | Xellia Pharmaceuticals USA LLC | 494b2aa1-020b-432c-977e-a5d74e31e342 | 2023-11-17 | Warnings, Adverse reactions | 70594-034-01 70594-034 70594003401 |
| Daptomycin | DAPTOMYCIN | Xellia Pharmaceuticals USA LLC | fc7eef03-042b-44a1-a344-1fa8a0435900 | 2023-08-04 | Warnings, Adverse reactions | 70594-034 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.